Neurogene's total assets for Q3 2025 were $287.83M, a decrease of -3.19% from the previous quarter. NGNE total liabilities were $22.29M for the fiscal quarter, a -7.35% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.